Near‐infrared photoimmunotherapy targeting EGFR—Shedding new light on glioblastoma treatment

Glioblastomas (GBMs) are high‐grade brain tumors, differentially driven by alterations (amplification, deletion or missense mutations) in the epidermal growth factor receptor (EGFR), that carry a poor prognosis of just 12–15 months following standard therapy. A combination of interventions targeting...

Descripción completa

Detalles Bibliográficos
Autores principales: Burley, Thomas A., Mączyńska, Justyna, Shah, Anant, Szopa, Wojciech, Harrington, Kevin J., Boult, Jessica K.R., Mrozek‐Wilczkiewicz, Anna, Vinci, Maria, Bamber, Jeffrey C., Kaspera, Wojciech, Kramer‐Marek, Gabriela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Cancer Therapy and Prevention
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6016485/
https://www.ncbi.nlm.nih.gov/pubmed/29313975
http://dx.doi.org/10.1002/ijc.31246

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6016485/
https://www.ncbi.nlm.nih.gov/pubmed/29313975
http://dx.doi.org/10.1002/ijc.31246

Ejemplares similares